Patent · US Active

Anti-CTLA4 antibodies and uses thereof

US12054547B2 · kind B2 · utility

0Cited by

7References

18Claims

0Family size

Assignee

Eucure (Beijing) Biopharma Co., Ltd · CN

Inventors

Yi Yan Yang · Singapore, SG
Yanan Guo · Beijing, CN
Xiaodong Cheng · Beijing, CN
Yunyun Chen · Beijing, CN
Jingshu Xie · Beijing, CN
Chunyan Dong · Beijing, CN
Fang Yang · Beijing, CN
Chengyuan Lu · Beijing, CN
Yuelei Shen · Beijing, CN
Jian Ni · Rockville, US

Key dates

Filing date	Feb 22, 2021
Grant date	Aug 6, 2024
Priority date	—
Expiry date	Jun 9, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.